Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis

BACKGROUND: Many studies have combined sorafenib with transcatheter arterial chemoembolization (TACE) to treat patients with advanced hepatocellular carcinoma (HCC), but the results are disputable. Thus, we conducted this meta-analysis to assess the efficacy and safety of the combination treatment i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Rong, Song, Rongfeng, Pang, Pengfei, Yan, Yan, Liao, Yifeng, Zhou, Cuiling, Wang, Shuncong, Zhou, Xiuling, Wang, Huaping, Zhang, Hongyu, Sun, Huanhuan, Ma, Haiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674853/
https://www.ncbi.nlm.nih.gov/pubmed/29110700
http://dx.doi.org/10.1186/s12885-017-3707-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674853/
https://www.ncbi.nlm.nih.gov/pubmed/29110700
http://dx.doi.org/10.1186/s12885-017-3707-5

Ejemplares similares